Catalyst
Slingshot members are tracking this event:
Regeneron (REGN) and Sanofi (SNY) Announce Approval of Kevzara (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the European Union
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 27, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sarilumab, Kevzara, Rheumatoid Arthritis
